GOT1 and pancreatic neoplasm: GOT1 ectopic expression restrained miR-433-3p-mediated influences on tumor development and glutamine catabolism, suggesting GOT1 could hinder malignant properties of pancreatic cancer, which was approved by the data from Wang et al [23].